CMND Stock Earnings: Clearmind Medicine Reported Results for Q2 2024

Date:

June 18, 2024

Clearmind Medicine (NASDAQ:CMND) just reported results for the second quarter of 2024.

Clearmind Medicine reported earnings per share of -28 cents.
The company did not report any revenue for the quarter.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Go Source

EBF Stock Earnings: Ennis Beats EPS, Beats Revenue for Q1 2024

Why Is Mustang Bio (MBIO) Stock Up 347% Today?